231 related articles for article (PubMed ID: 23756862)
1. Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma.
Gordziel C; Bratsch J; Moriggl R; Knösel T; Friedrich K
Br J Cancer; 2013 Jul; 109(1):138-46. PubMed ID: 23756862
[TBL] [Abstract][Full Text] [Related]
2. The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels.
Isomäki P; Junttila I; Vidqvist KL; Korpela M; Silvennoinen O
Rheumatology (Oxford); 2015 Jun; 54(6):1103-13. PubMed ID: 25406356
[TBL] [Abstract][Full Text] [Related]
3. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma.
Denley SM; Jamieson NB; McCall P; Oien KA; Morton JP; Carter CR; Edwards J; McKay CJ
J Gastrointest Surg; 2013 May; 17(5):887-98. PubMed ID: 23435739
[TBL] [Abstract][Full Text] [Related]
4. Targeting STAT proteins via computational analysis in colorectal cancer.
Dariya B; Muppala S; Srivani G; Momin S; Alam A; Saddala MS
Mol Cell Biochem; 2021 Jan; 476(1):165-174. PubMed ID: 32840738
[TBL] [Abstract][Full Text] [Related]
5. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6.
Galdiero M; Vitiello M; D'Isanto M; Raieta K; Galdiero E
Cytokine; 2006 Dec; 36(5-6):218-28. PubMed ID: 17258468
[TBL] [Abstract][Full Text] [Related]
6. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
[TBL] [Abstract][Full Text] [Related]
7. Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.
Wilmes S; Jeffrey PA; Martinez-Fabregas J; Hafer M; Fyfe PK; Pohler E; Gaggero S; López-García M; Lythe G; Taylor C; Guerrier T; Launay D; Mitra S; Piehler J; Molina-París C; Moraga I
Elife; 2021 Apr; 10():. PubMed ID: 33871355
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA 452 regulates IL20RA-mediated JAK1/STAT3 pathway in inflammatory colitis and colorectal cancer.
Lamichhane S; Mo JS; Sharma G; Choi TY; Chae SC
Inflamm Res; 2021 Aug; 70(8):903-914. PubMed ID: 34283251
[TBL] [Abstract][Full Text] [Related]
9. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
10. Interplay of transcription factors STAT3, STAT1 and AP-1 mediates activity of the matrix metallo-proteinase-1 promoter in colorectal carcinoma cells.
Muller A; Gasch J; Albring KF; Aberger F; Nivarthi H; Khemeri M; Moriggl R; Friedrich KH
Neoplasma; 2019 May; 66(3):357-366. PubMed ID: 30569725
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC.
Wang S; Zhang W
Tumour Biol; 2016 May; 37(5):6561-9. PubMed ID: 26638167
[TBL] [Abstract][Full Text] [Related]
12. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory Cytokines IL-6 and TNF-
Chung SS; Wu Y; Okobi Q; Adekoya D; Atefi M; Clarke O; Dutta P; Vadgama JV
Mediators Inflamm; 2017; 2017():5958429. PubMed ID: 28676732
[TBL] [Abstract][Full Text] [Related]
15. Are STATS arginine-methylated?
Komyod W; Bauer UM; Heinrich PC; Haan S; Behrmann I
J Biol Chem; 2005 Jun; 280(23):21700-5. PubMed ID: 15826948
[TBL] [Abstract][Full Text] [Related]
16. The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review).
Wang SW; Sun YM
Int J Oncol; 2014 Apr; 44(4):1032-40. PubMed ID: 24430672
[TBL] [Abstract][Full Text] [Related]
17. Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.
Zheng X; Li AS; Zheng H; Zhao D; Guan D; Zou H
PLoS One; 2015; 10(3):e0119780. PubMed ID: 25781885
[TBL] [Abstract][Full Text] [Related]
18. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation.
Gerhartz C; Heesel B; Sasse J; Hemmann U; Landgraf C; Schneider-Mergener J; Horn F; Heinrich PC; Graeve L
J Biol Chem; 1996 May; 271(22):12991-8. PubMed ID: 8662591
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6--a key regulator of colorectal cancer development.
Waldner MJ; Foersch S; Neurath MF
Int J Biol Sci; 2012; 8(9):1248-53. PubMed ID: 23136553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]